Lipase inhibitor, Clofibrate, Purity ≥98%

Synonym: 637-07-0; Ethyl clofibrate; Atromid-S; Atromid; Liprin; Clofibratum; Clofibrato; EPIB; Arterioflexin; Chlorphenisate; Anparton; Antilipid; Antilipide; Arterosol; Ateculon; Ateriosan; Athebrate; Atheromide; Atheropront; Atromida; Clofibate; Lipavlon; Lipofacton; Liprinal; Miscleron; Ticlobran; Amotril; Apolan; Atrolen; Lipavil; Lipomid; Xyduril; Amotril S; Angiokapsul; Atromidin; Bioscleran; Clofibram; Clofibrat; Clofipront; Hyclorate; Klofibrat; Lipidsenker; Liporeduct; Persantinat; Serotinex; Skleromexe; Athranid-wirkstoff; Atrovis; Azionyl; Cartagyl; Citiflus; Claripex; Clobrat; Clofinit; Fibralem; Gerastop; Klofiran; Levatrom; Lipamid; Liponorm; Liporil; Liposid; Lobetrin; Normalip; Regardin; Regelan; Bresit; Clofar; Deliva; Ethyl chlorophenoxyisobutyrate; Normat; Sklero; Dura clofibrat; Sklero-Tablinen; neo-Atomid; Neo-Atromid; Atromid S; Clobren-SF; Claripex CPIB; Cinnarizin; Cloberat; CPIB; ELPI; Misclerone; Normolipol; Robigram; Skerolip; Artevil; Delipid; Negalip; Normet; Recolip; Scrobin; Yoclo; Sklero-tabuls; Regelan N; Lipide 500; 2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester; Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate; Lipase inhibitor

MDL: MFCD00000615
CAS Number: 637-07-0
Compound CID: 2796

Product Size

500 mg; 1 g; 2 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Clofibrate, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lipase. The molecular weight of the compound is 242.7, and its molecular formula is C₁₂H₁₅ClO₃. It targets the PPARα and PPARγ.

Molecular Weight

242.7

Molecular Formula

C₁₂H₁₅ClO₃

Targets

PPARα

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 7 mg/mL (28.84 mM); Water: insoluble; Ethanol: 5 mg/mL (20.6 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Clofibrate can be used for its ability to reduce triglyceride levels and increase HDL cholesterol, which can be beneficial in managing dyslipidemia.